From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret value.

The 15-year OS rate was 60% among prostate brachytherapy recipients and 55% among EBRT recipients, indicating no significant difference between the arms. In prostate cancer, prostate brachytherapy (PB ...

A Hawke’s Bay man has become the first patient in the region to receive low-dose-rate (LDR) brachytherapy, a “minimally invasive” internal radiotherapy treatment for prostate cancer. Nick Mardle, 64, ...

Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group Study AALL03N1 ...

In this analysis, researchers aimed to discover whether the extended freedom from biochemical failure seen with prostate brachytherapy boost would lead to improved overall survival in prostate cancer.